Source: Eur Respir Rev 2010 19: 272-278
Disease area: Pulmonary vascular diseases



Rating:

Share or cite this content

Citations should be made in the following way:
Sitbon O., Galiè N.. Treat-to-target strategies in pulmonary arterial hypertension: the importance of using multiple goals. Eur Respir Rev 2010 19: 272-278

Member's Comments

No comment yet.

Related content which might interest you: Management of severe pulmonary arterial hypertension Source: Eur Respir Rev 2010 19: 279-287 Year: 2010 The prognostic impact of follow-up assessments in patients with idiopathic pulmonary arterial hypertension Source: Eur Respir J 2012; 39: 589-596 Year: 2012 Early intervention in pulmonary arterial hypertension associated with systemic sclerosis: an essential component of disease management Source: Eur Respir Rev 2010 19: 314-320 Year: 2010 Paediatric pulmonary arterial hypertension: updates on definition, classification, diagnostics and management Source: Eur Respir J, 53 (1) 1801916; 10.1183/13993003.01916-2018 Year: 2019 A regional nurse study day using small group tutorials- A successful novel approach to publicising pulmonary hypertension Source: Annual Congress 2013 –Improving educational programmes for patients and multidisciplinary healthcare professionals Year: 2013 Effect of sildenafil on exercise ability of patients with World Health Organization functional class II pulmonary arterial hypertension Source: Annual Congress 2009 - Treatment of airways disease Year: 2009 Pulmonary hypertension: diagnosis, differential diagnosis and pitfalls Source: Eur Respir Mon 2012; 57: 17-25 Year: 2012 Impact of treatment strategy in survival of patients with idiopathic pulmonary arterial hypertension. Real world evidence from Spanish National Pulmonary Hypertension Registry (REHAP) Source: International Congress 2018 – Pulmonary hypertension: therapy Year: 2018 Heart rate recovery in response to disease targeted therapy in pre-capillary pulmonary hypertension Source: International Congress 2016 – Pulmonary hypertension: exercise, haemodynamics, and physiology Year: 2016 Assessing the financial impact of pulmonary hypertension: a survey by the UK Pulmonary Hypertension Association (PHA-UK) Source: International Congress 2018 – Clinical aspects of pulmonary hypertension Year: 2018 Issues related to the management and therapy of paediatric pulmonary hypertension Source: Eur Respir Rev 2010 19: 331-339 Year: 2010 Survival in pulmonary arterial hypertension: a reappraisal of the NIH risk stratification equation Source: Eur Respir J 2010; 35: 1079-1087 Year: 2010 Paediatric pulmonary hypertension: monitoring progress and identifying unmet needs Source: Eur Respir Rev 2009; 18: 18-23 Year: 2009 Pulmonary hypertension: new guidelines for therapy Source: Annual Congress 2007 - PG19 - Pulmonary vascular disorders: diagnosis and treatment Year: 2007 An evaluation of outcomes for patients with pulmonary hypertension (PH) incorporated into a standard UK pulmonary rehabilitation (PR) programme Source: International Congress 2016 – Pulmonary hypertension: the clinic II Year: 2016 Relation of American Heart Association’s life’s simple 7 cardiovascular health factors with chronic obstructive pulmonary disease Source: International Congress 2016 – Comorbidities and exacerbations in COPD Year: 2016 PAH-specific therapies improve survival in patients with pulmonary arterial hypertension associated with connective tissue diseases: A Russian single centre experience Source: International Congress 2014 – Pulmonary hypertension: novel targets and drugs Year: 2014 Treatment options for paediatric pulmonary arterial hypertension Source: Eur Respir Rev 2010 19: 321-330 Year: 2010 The role of right heart catheterization prior to initiation of PAH specific therapy Source: Annual Congress 2013 –Pulmonary circulation: clinical pulmonary hypertension I Year: 2013